Skip to main content
. Author manuscript; available in PMC: 2013 Nov 13.
Published in final edited form as: J Am Coll Cardiol. 2012 Oct 17;60(20):2092–2099. doi: 10.1016/j.jacc.2012.07.046

Figure 4.

Figure 4

Kaplan-Meier estimates of event-free survival of symptomatic patients initiated on different beta-blockers.

The cumulative event-free survival of symptomatic patients initiated on metoprolol (n=35) was significantly different (p=0.02) from those initiated on propranolol and nadolol combined (n=66).